CRYO CELL INTERNATIONAL INC (CCEL) — Insider Trading

AI-Powered SEC Filing Analysis

Latest Insider Trading Filed: 2026-01-09

Key Insights

The reporting person, Jill M. Taymans, who is the VP Finance and CFO of Cryo-Cell International Inc. (CCEL), disposed of 45,396 shares of the company's common stock.
The reporting person was also granted 10,000 and 20,000 stock options with an exercise price of $3.54, which vest over a multi-year period and are subject to stock price performance conditions.
The insider transactions and option grants suggest continued executive involvement and confidence in the company's future performance.

Want the newest filings?

This analysis covers the filing from 2026-01-09. New 10-K, 10-Q and 8-K filings are analyzed the moment they are released — exclusively in the app.

Download on the App Store Open in app →

Earlier Insider Trading filings

Filed: 2026-01-09

Mark Portnoy, the Co-CEO and a 10% owner of Cryo-Cell International Inc, purchased 50,000 stock options and 25,000 stock options with an exercise price of $3.89 on January 7, 2026. This suggests Portnoy's confidence in the company's future performance.
The stock options granted to Portnoy are subject to both time-based vesting and stock price performance conditions, requiring the company's stock to reach certain price targets over the next few years. This aligns Portnoy's incentives with shareholders' long-term interests.
Portnoy also holds a significant direct and indirect ownership stake in Cryo-Cell, with over 935,000 shares beneficially owned. His substantial investment in the company's equity suggests he is deeply committed to the firm's success.

Filed: 2026-01-09

Oleg Mikulinsky, the Chief Information Officer of Cryo-Cell International Inc. (CCEL), has exercised 30,000 stock options with a strike price of $3.54 on January 7, 2026.
The options are divided into three equal tranches with time-based vesting and stock-price performance conditions, incentivizing Mikulinsky to drive the company's stock price higher.
This insider buying activity suggests Mikulinsky's confidence in the company's future prospects and aligns his interests with those of CCEL's shareholders.

Filed: 2026-01-09

David Portnoy, the Chairman and Co-CEO of Cryo-Cell International Inc (CCEL), has acquired a significant amount of CCEL stock through various means, including direct purchases, shares held through corporations, and shares held in retirement and personal accounts.
Portnoy has been granted several stock options with varying exercise prices and vesting schedules, indicating the company's efforts to incentivize and retain its top executive.
The vesting of some of the stock options is tied to the company's stock price reaching certain performance thresholds, aligning Portnoy's interests with those of other shareholders.

Other reports for CRYO CELL INTERNATIONAL INC

Current Report Quarterly Report Annual Report

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.